Steritas’ Post

Inflammatory bowel disease (#IBD) is a chronic progressive disease affecting the gastrointestinal tract and its global incidence is rising every year. The effectiveness of steroids in inducing remission has been recognized since the 1950s, and they are still widely used for this purpose today. However, read on to learn more about the overlooked impact of #SteroidToxicity and the effects its having for patients worldwide: Steroids Pose Immense Risk of Increased Morbidity to IBD Patients https://hubs.li/Q02mBp9S0 #RareDiseaseDay #InflammatoryBowelDisease #CrohnsDisease #UlcerativeColitis #SteritasGTI #PatientCare #RareDiseases #Treatment #Healthcare

Great piece from Steritas highlighting the impact of steroid toxicity on patients with #IBD with insights from LeaAnn Chen.

More than 6.8 million people suffer with inflammatory bowel disease (#IBD), many of whom are at risk of increased morbidity due to an overreliance on steroids for treatment. Read on to discover the impact of #SteroidToxicity in patients with IBD and why finding steroid-sparing alternatives is critical to their wellbeing: https://hubs.li/Q02lg5Pl0 #InflammatoryBowelDisease #CrohnsDisease #UlcerativeColitis #SteritasGTI #PatientCare #RareDiseases #Treatment #Healthcare

More than 6.8 million people suffer with inflammatory bowel disease (#IBD), many of whom are at risk of increased morbidity due to an overreliance on steroids for treatment. Read on to discover the impact of #SteroidToxicity in patients with IBD and why finding steroid-sparing alternatives is critical to their wellbeing: https://hubs.li/Q02lgg0n0 #InflammatoryBowelDisease #CrohnsDisease #UlcerativeColitis #SteritasGTI #PatientCare #RareDiseases #Treatment #Healthcare

【A Case of Euglycemic Diabetic Ketoacidosis in Patient with Type 2 DM】 Full article: https://lnkd.in/gz4Yvbsu (Authored by Lamiz Tannouri, et al., from Soliman Fakeeh University Hospital, United Arab Emarites.) Euglycemic diabetic ketoacidosis (#EDKA) is a rare syndrome that can occur in type 1 (T1DM) and type 2 (T2DM) diabetes mellitus. It is also a challenging diagnosis. This case report describes a male patient who was diagnosed with type 2 DM, 1 week prior to his symptoms and admission in hospital and displayed severe acidemia and ketonemia despite normal #glucose_levels at the time of presentation to the ED, and was finally diagnosed with EDKA. #Acidosis

💉 Calling all rheumatologists: consider using intravenous methylprednisolone (125 - 500 mg daily X 3 doses) at diagnosis time in #SLE #lupus to increase the chances for long-term remission in those with moderate to severe disease: https://lnkd.in/eSnyX6Re

If you have concerns about whether GLP-1 medications can be taken with conditions like Crohn’s disease or ulcerative colitis, you can rest assured that it's generally considered safe to do so. In fact, it's possible these medications could help with IBD. Obesity and IBD are both involved in chronic inflammation. When this inflammation is reduced through medication-assisted weight loss, this could help alleviate the symptoms of IBD. At the end of the day, everyone responds differently to these medications, so it's important to talk through your options with your Mochi Health provider. Read more on the link between obesity medicine and IBD here: https://ow.ly/PIYh50RERwG

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐂𝐚𝐮𝐬𝐞 𝐨𝐟 𝐈𝐁𝐃 With the identification of a primary cause of inflammatory bowel disease (IBD) and the realization that the illness may be treated with currently available medications, researchers have achieved “huge strides forward.” 𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://cutt.ly/ReiEtl3C #IBDResearch #GutHealth #MedicalBreakthrough #HealthInnovation #IBDAwareness #InflammatoryBowelDisease #HealthcareNews #ScientificDiscovery #EuroHealthLeaders

Ulcerative colitis is an inflammatory bowel disease that causes inflammation and ulcers in the digestive tract. Ulcerative colitis can be taxing and sometimes lead to life-threatening complications. While there is no known cure, there are several new therapies that can significantly decrease the signs and symptoms of the disease and achieve long-term remission. When choosing a specialty pharmacy to support patients with ulcerative colitis, it is important to select a provider with extensive experience in rare disease treatment and management. Read more here- https://bit.ly/49z06WL

Growing mini-organs to find new treatments for complex disease Mayo Clinic investigators are growing three-dimensional human intestines in a dish to track disease and find new cures for complex conditions such as inflammatory bowel disease. These mini organs function like human intestines with the ability to process metabolites that convert food into energy on a cellular level and secrete mucus that protects against bacteria. These 3D mini intestines in a dish, known as "organoids," provide a unique platform for studying the intricacies of the human gut. A growing health problem Inflammatory bowel disease is a growing worldwide health problem that affects approximately 3 million people in the U.S., according to the Centers for Disease Control. It encompasses a group of inflammatory conditions that affect the digestive system such as Crohn's disease and ulcerative colitis. Symptoms of inflammatory bowel disease include abdominal pain and diarrhea but vary widely from one person to the next, posing a challenge in finding successful treatments. Immunotherapies are commonly prescribed but are effective only 40% of the time, and few patients experience lasting relief. Intestinal organoids provide a new, humanlike tool for tracking inflammatory bowel disease. "A combination of animal and human models is more effective for our research. Intestinal organoids have the potential to allow us to screen drugs for toxicity and monitor effectiveness before the drug is tested in a clinical trial," says Dr. Druliner. A Mayo Clinic research team including Dr. Druliner and William Faubion, Jr., M.D., a gastroenterologist-researcher and medical director for Mayo Clinic's Center for Regenerative Biotherapeutics, is using these intestinal organoids to recreate features of inflammatory bowel disease. https://lnkd.in/et_t5tzN